胸腺肽α1治疗慢性阻塞性肺疾病稳定期疗效观察(1)
第1页 |
参见附件(1346KB,2页)。
【摘要】目的:观察胸腺肽α1治疗慢性阻塞性肺疾病稳定期的临床疗效。方法:将100例慢性阻塞性肺疾病稳定期患者随机单盲分为2组,治疗组在常规综合治疗基础上加用胸腺肽α11.6mg皮下注射,隔日1次(qod),疗程共半月,对照组采用常规综合治疗,观察两组治疗前后临床肺功能和实验室指标改善情况。两组治疗3月后总结临床疗效。结果:治疗组肺功能、氧分压、二氧化碳分压、pH、临床症状、TLC、CD+4、CD+8、CD+4/CD+8等改善明显优于对照组,而且无明显不良反应。治疗组、对照组治疗3月后总有效率分别为88%、64%。结论:在常规治疗基础上加用胸腺肽α1治疗慢性阻塞性肺疾病稳定期,临床疗效明显提高。
【关键词】慢性阻塞性肺疾病稳定期;胸腺肽α1
The Clinical Observation of Thymosin-α1 on treatment
of stable phase of Chronic Obstructive Pulmonary Disease
HUANG Wenting OU Yangfan WEI LiJuan CHEN Ping
【Abstract】ObjectiveThis study was conducted to observe the effectof Thymosin-α1 on treatment of stable phase of Chronic Obstructive Pulmonary Disease.MethodsIn a partially randomized single-blind clinical trial, 100 patients with stable phase of chronic obstructive pulmonary disease patients were divided into control and treatment groups ......
您现在查看是摘要介绍页,详见PDF附件(1346KB,2页)。